Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monte Rosa Therapeutics

12.50
+0.18001.46%
Volume:666.72K
Turnover:8.24M
Market Cap:771.99M
PE:42.49
High:12.69
Open:12.26
Low:11.98
Close:12.32
52wk High:12.69
52wk Low:3.50
Shares:61.76M
Float Shares:30.30M
Volume Ratio:1.17
T/O Rate:2.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2942
EPS(LYR):-0.9836
ROE:9.81%
ROA:2.66%
PB:2.88
PE(LYR):-12.71

Loading ...

Monte Rosa Therapeutics Initiates Phase 1 Study of NEK7-Directed Molecular Glue Degrader MRT-8102 for Inflammatory Diseases

Reuters
·
Aug 07

Monte Rosa Therapeutics Announces Second Quarter 2025 Financial Results and Business Updates

THOMSON REUTERS
·
Aug 07

Monte Rosa Therapeutics Inc - Cash Position Expected to Fund Operations Into 2028

THOMSON REUTERS
·
Aug 07

Monte Rosa Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
Aug 04

Monte Rosa Therapeutics Doses First Patients in Study of Inflammatory Disease Treatment

MT Newswires Live
·
Jul 21

BRIEF-Monte Rosa Therapeutics Announces First Subjects Dosed In Phase 1 Study Of Mrt-8102, A Nek7-Directed Molecular Glue Degrader For The Treatment Of Multiple Inflammatory Diseases

Reuters
·
Jul 21

Monte Rosa Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 14

BRIEF-Monte Rosa Therapeutics Announces FDA Clearance Of Ind Application For Mrt-8102

Reuters
·
Jun 10

Edmund Dunn, Principal Accounting Officer, Reports Disposal of Common Shares in Monte Rosa Therapeutics Inc

Reuters
·
Jun 05

Monte Rosa Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Monte Rosa Therapeutics Q1 EPS $0.57 Beats $(0.30) Estimate, Sales $84.93M Beat $14.25M Estimate

Benzinga
·
May 08

BRIEF-Monte Rosa Therapeutics Q1 Net Income USD 47.707 Million

Reuters
·
May 08

Press Release: Monte Rosa Therapeutics Announces First Quarter 2025 Financial Results and Business Updates

Dow Jones
·
May 08

Monte Rosa Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
May 05